HY8-62680-89847
3 vaccinations
3 coded responses
28 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 961 / CA
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Dose 2 — Pfizer-BioNTech
-
2021-03-19
Registered in v-safe
-
2021-03-19
Survey response — days 1–6 daily, dose 2MedDRA: Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: FaintingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
-
2021-06-17
Survey response — 3 months, dose 2MedDRA: Fibrocystic breast disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed w/fibrocystic brrastsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-17
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-19
-
2021-06-22
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-09-16
Survey response — 6 months, dose 2MedDRA: Hypothyroidism — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HypothyroidismMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-21
-
2021-12-06
Dose 3 — Moderna
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · DiarrheaAdult check-in
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · HeadacheAdult check-in
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-01-10
- 2022-01-17
- 2022-03-09
- 2022-06-07
- 2022-12-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech | |
| 3 | 2021-12-06 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Fainting
Release 9 — 3 months, dose 2
Symptoms: Diagnosed w/fibrocystic brrasts
Release 9 — 6 months, dose 2
Symptoms: Hypothyroidism
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fibrocystic breast disease | ✓ | ✓ | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Pre-existing disease | ○ | ○ | ○ |
| SRO | Syncope | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release